ESR1 and breast cancer: Upon close examination, PRSS23 expression was found to be much higher in the nucleoplasm of ERα-positive breast cancer specimens (Fig. 2G, H, I) compared with the nucleoplasm of ERα-negative breast cancer specimens (Fig. 2J, K, L).